Lorundrostat
MLS-101-207
Phase 2 small_molecule completed
Quick answer
Lorundrostat for Obstructive Sleep Apnea is a Phase 2 program (small_molecule) at Mineralys Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mineralys Therapeutics
- Indication
- Obstructive Sleep Apnea
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed